Efficacy and safety of sibeprenlimab in IgA nephropathy: a systematic review and meta-analysis of randomized controlled trials

Authors

Zhonghua Tian (ORCID: https://orcid.org/0000-0002-5158-876X)
Yuxia Li

Institutions

Chongqing Emergency Medical Center (CN)
First People's Hospital of Chongqing (CN)

Publication Details

Journal: BMC Nephrology
Published: 2026-03-28
DOI: https://doi.org/10.1186/s12882-026-04927-9
Primary Topic: Renal Diseases and Glomerulopathies
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Efficacy and safety of sibeprenlimab in IgA nephropathy: a systematic review and meta-analysis of randomized controlled trials

Zhonghua Tian, Yuxia Li

Mar 28, 2026

BMC Nephrology

Renal Diseases and Glomerulopathies

article

Efficacy and safety of sibeprenlimab in IgA nephropathy: a systematic review and meta-analysis of randomized controlled trials

Zhonghua Tian, Yuxia Li

March 28, 2026article en

Abstract

No abstract available for this paper.

BMC Nephrology

Chongqing Emergency Medical Center (CN), First People's Hospital of Chongqing (CN)

Good health and well-being

Openalex Percentile: Top 3%

Renal Diseases and Glomerulopathies

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and safety of sibeprenlimab in IgA nephropathy: a systematic review and meta-analysis of randomized controlled trials — Zhonghua Tian, Yuxia Li · BMC Nephrology (2026) | TGRS Research Map | TGRS